Product Number |
ARP60593_P050 |
Product Page |
www.avivasysbio.com/fgfbp2-antibody-c-terminal-region-arp60593-p050.html |
Name |
FGFBP2 Antibody - C-terminal region (ARP60593_P050) |
Protein Size (# AA) |
223 amino acids |
Molecular Weight |
24kDa |
NCBI Gene Id |
83888 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
0.5 mg/ml |
Gene Full Name |
Fibroblast growth factor binding protein 2 |
Alias Symbols |
KSP37, HBP17RP |
Peptide Sequence |
Synthetic peptide located within the following region: LGKAKPTTRPTAKPTQPGPRPGGNEEAKKKAWEHCWKPFQALCAFLISFF |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Description of Target |
FGFBP2 is a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma. |
Protein Interactions |
APP; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-FGFBP2 (ARP60593_P050) antibody |
Blocking Peptide |
For anti-FGFBP2 (ARP60593_P050) antibody is Catalog # AAP60593 (Previous Catalog # AAPP46632) |
Immunogen |
The immunogen is a synthetic peptide directed towards the C terminal region of human FGFBP2 |
Uniprot ID |
Q9BYJ0 |
Protein Name |
Fibroblast growth factor-binding protein 2 |
Protein Accession # |
NP_114156 |
Purification |
Affinity Purified |
Nucleotide Accession # |
NM_031950 |
Tested Species Reactivity |
Human |
Gene Symbol |
FGFBP2 |
Predicted Species Reactivity |
Human |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Human: 100% |
Image 1 | Human HeLa
| WB Suggested Anti-FGFBP2 Antibody Titration: 0.2-1 ug/ml ELISA Titer: 1:312500 Positive Control: Hela cell lysate |
|
|